Dapxiga 5mg Tablet

Dapxiga 5mg Tablet contains Dapagliflozin as its active ingredient. It is classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor medication. Dapagliflozin is primarily used to help manage type 2 diabetes mellitus by aiding in the reduction of blood sugar levels. This is achieved by inhibiting the reabsorption of glucose in the kidneys, resulting in increased urinary glucose excretion and lowered blood glucose levels.

Uses:

Dapxiga 5mg Tablet is prescribed for the treatment of type 2 diabetes mellitus. It is employed as an adjunct to diet and exercise to improve glycemic control in individuals who have not achieved sufficient glucose regulation with other antidiabetic medications alone. Dapagliflozin assists in lowering blood sugar levels by facilitating the elimination of glucose in the urine, thereby mitigating the risk of hyperglycemia and its associated complications.

Dosage:

The dosage of Dapxiga 5mg Tablet is determined based on individual patient response, medical history, and renal function. Typically, it is taken orally once daily, either with or without food, as directed by a healthcare professional. Patients should strictly adhere to the prescribed dosage regimen and regularly monitor their blood sugar levels to assess treatment effectiveness. The tablet should be swallowed whole with a glass of water and should not be crushed, chewed, or divided.

Side Effects:

Common side effects associated with Dapxiga 5mg Tablet may include urinary tract infections, genital yeast infections, increased urination, thirst, and hypotension (low blood pressure). While these side effects are usually mild to moderate and temporary, they may resolve with continued use or upon discontinuation of the medication. However, in some instances, more severe side effects such as ketoacidosis, dehydration, or allergic reactions may occur. Patients should promptly report any unusual or persistent side effects to their healthcare provider.

Precautions:

Prior to using Dapxiga 5mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is crucial to exercise caution in patients with impaired renal function or a history of urinary tract infections. Dapagliflozin may interact with certain medications, necessitating a review of the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Dapxiga 5mg Tablet is contraindicated in patients with a known hypersensitivity to Dapagliflozin or any other components of the medication. It is not suitable for use in individuals with type 1 diabetes mellitus or diabetic ketoacidosis. Furthermore, this medication is not recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.